Delivery Order SPE2DB25D7067-SPE2DB25FSVLS
Award Date 8/3/25
Potential Completion Date 8/4/25
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price delivery order with a ceiling value of $4,741.01 and an ultimate completion date of August 4, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- On August 1, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,774.03 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed price contract represents a non-competitive award and is scheduled for completion by August 4, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order operates as a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Procainamide 1 gram/10 mL vials. This firm fixed-price delivery order, valued at $6,447.79, is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,425.06 for the procurement of Procainamide 1 gram/10 ml vials. The contract has a period of performance through May 21, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,050.22 firm-fixed-price contract is for the supply of 4565366751 - Procainamide 1,000 mg/2 ml vials. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen is a large pharmaceutical distributor that has been awarded multiple federal contracts to provide a wide range of medical commodities, including specialty medications, vaccines,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Procainamide 1,000 mg/2 mL vials with a contract value of $6,203.12 and an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat abnormal heart rhythms and is a critical pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,959,694 units of Procainamide 1,000 mg/10 ml vial. The contract has a ceiling value of $2,126.25 and is a firm fixed price delivery order. It does not have a set-aside designation. The contract has an ultimate completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $1,704.20 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Procainamide is an...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,395.40, is for the delivery of Procainamide 1 gram/10 ml vials, a pharmaceutical product used for medical purposes. The contract is a Firm Fixed Price (FFP) delivery order with a performance period through June 30, 2025. It is not set aside for any specific business category....